Bruce Beutler, M.D., is a Nobel laureate credited with developing groundbreaking methods to block the immune system’s inflammatory reaction. His research has resulted in therapies and improved outcomes for people with chronic inflammatory diseases; specifically, Dr. Beutler created recombinant inhibitors of Tumor Necrosis Factors (TNF), now widely used as Enbrel, a first-line treatment for people suffering from rheumatoid arthritis, psoriasis, ankylosing spondylitis, juvenile rheumatoid arthritis and other autoimmune disorders.
Dr. Beutler, Regental Professor and Director of the Center for Genetics of Host Defense at the University of Texas Southwestern Medical Center, was recognized with the 2009 Albany Medical Center Prize in Medicine and Biomedical Research—one of America’s largest such prizes—for his work.
Beutler has received many other prestigious national and international awards and honors including the Nobel Prize in Physiology or Medicine (2011),the Shaw Prize (2011), the National Academy of Sciences (2008), the Balzan Prize (2007) and the Gran Prix Charles-Leopold Mayer from the Academie des Sciences in France (2006). He is also affiliated with the International Mammalian Genome Society, the Society of Innate Immunity, The American Association of Immunologists, The Institute of Medicine, and The National Academy of Sciences.
Dr. Beutler will receive an honorary degree, as will Albany philanthropist Morris Massry, owner of Tri-City Rentals and President of the Massry Charitable Foundation.